Changes in fibroblast growth factor 23 levels in normophosphatemic patients with chronic kidney disease stage 3 treated with lanthanum carbonate: results of the PREFECT study, a phase 2a, double blind, randomized, placebo-controlled trial

✍ Scribed by Ureña-Torres, Pablo; Prié, Dominique; Keddad, Karim; Preston, Peter; Wilde, Paul; Wan, Hong; Copley, J

• Book ID: 125398619
• Publisher: BioMed Central
• Year: 2014
• Tongue: English
• Weight: 220 KB
• Volume: 15
• Category: Article
• ISSN: 1471-2369
• DOI: 10.1186/1471-2369-15-71